{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:16:17Z","timestamp":1788419777899,"version":"build-2803163510"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study evaluates the analytical validity of capillary blood for Krebs von den Lungen-6 (KL-6) detection using a high-sensitivity chemiluminescent immunoassay (CLIA) on the C5000 analyser and assesses agreement between capillary plasma and venous plasma measurements, with emphasis on methodological feasibility rather than clinical diagnostic performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Analytical performance was assessed in terms of repeatability, accuracy and method comparison. Precision was evaluated using pediatric venous plasma samples at three concentration levels, each tested in 20 replicates. Accuracy was verified using manufacturer standards and external quality controls. Comparative analysis involved 80 paired venous plasma and capillary blood samples, with hematocrit (HCT)-based correction applied to address dilutional effects. Agreement between venous and capillary plasma measurements was evaluated using Passing\u2013Bablok regression, Pearson correlation and Bland\u2013Altman analysis. Pediatric and adult KL-6 levels were also profiled to evaluate age-specific differences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The C5000 analyzer demonstrated excellent repeatability, with coefficients of variation below 3% across all concentration levels. Accuracy assessment showed minimal bias relative to the standards and controls. Passing\u2013Bablok regression indicated proportional bias before HCT correction, with a slope of 0.769 (95% CI, 0.550\u20130.945). After correction, the slope was 1.004 (95% CI, 0.882\u20131.162) and the intercept was \u22127.03 U\/mL (95% CI, \u221226.97 to 9.76). The mean capillary-minus-venous bias decreased from \u221248.32 to \u22123.47 U\/mL, and the Pearson correlation coefficient increased from 0.958 to 0.966. Pediatric KL-6 levels were significantly lower than adult levels (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001), underscoring the need for pediatric-specific exploratory reference estimates and future diagnostic validation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>High-sensitivity CLIA on the C5000 analyzer supports the analytical feasibility of KL-6 measurement in pediatric capillary blood. HCT correction improved agreement with venous plasma measurements, although further validation is required before the two sample types can be considered interchangeable for individual clinical assessment and before formal reference intervals can be established.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1894242","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:45:36Z","timestamp":1788417936000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Analytical validation of capillary blood Krebs von den Lungen-6 measurement using a high- sensitivity chemiluminescent immunoassay in pediatric patients"],"prefix":"10.3389","volume":"13","author":[{"given":"Chengyuan","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Children\u2019s Hospital of Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Children\u2019s Hospital of Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Cao","sequence":"additional","affiliation":[{"name":"Nanjing Poclight Biotechnology Company Limited","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Children\u2019s Hospital of Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Children\u2019s Hospital of Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1041098","DOI":"10.3389\/fimmu.2022.1041098","article-title":"Krebs von den lungen-6 as a clinical marker for hypersensitivity pneumonitis: a meta-analysis and bioinformatics analysis.","volume":"13","author":"He","year":"2022","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"745233","DOI":"10.3389\/fimmu.2021.745233","article-title":"KL-6 as an immunological biomarker predicts the severity, progression, acute exacerbation, and poor outcomes of interstitial lung disease: a systematic review and meta-analysis.","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1080\/10408363.2024.2350374","article-title":"Research progress of KL-6 in respiratory system diseases.","volume":"61","author":"Gao","year":"2024","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1515\/cclm-2024-1089","article-title":"Krebs von den lungen-6 (KL-6) as a diagnostic and prognostic biomarker for non-neoplastic lung diseases.","volume":"63","author":"Achille","year":"2024","journal-title":"Clin Chem Lab Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1513\/AnnalsATS.201301-017ST","article-title":"An official American thoracic society workshop report: optimal lung function tests for monitoring cystic fibrosis, bronchopulmonary dysplasia, and recurrent wheezing in children less than 6 years of age.","volume":"10","author":"Rosenfeld","year":"2013","journal-title":"Ann Am Thorac Soc"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1515\/cclm-2023-0928","article-title":"A comparison of cannabidiol (CBD) concentrations in venous vs. fingertip-capillary blood.","volume":"62","author":"Johnson","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3390\/diagnostics10040248","article-title":"Dried blood spot in laboratory: directions and prospects.","volume":"10","author":"Malsagova","year":"2020","journal-title":"Diagnostics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fmolb.2018.00070","article-title":"Precision medicine for neonatal sepsis.","volume":"5","author":"Ng","year":"2018","journal-title":"Front Mol Biosci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1106791","DOI":"10.3389\/fchem.2022.1106791","article-title":"Chemiluminescent polymeric nanoprobes for tumor diagnosis: a mini review.","volume":"10","author":"Zhang","year":"2023","journal-title":"Front Chem"},{"key":"B10","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1165\/rcmb.2005-0151OC","article-title":"The mucin-1 568 adenosine to guanine polymorphism influences serum krebs von den lungen-6 levels.","volume":"34","author":"Janssen","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.33073\/pjm-2023-043","article-title":"Diagnostic efficacy of photostimulated chemiluminescence assay for detecting Anti-HIV antibodies: a retrospective study.","volume":"72","author":"Han","year":"2023","journal-title":"Pol J Microbiol"},{"key":"B12","first-page":"119","article-title":"Therapies for neonatal diseases of the surfactant system.","volume":"135","author":"McCray","year":"2025","journal-title":"Trans Am Clin Climatol Assoc."},{"key":"B13","doi-asserted-by":"publisher","first-page":"875015","DOI":"10.3389\/fgene.2022.875015","article-title":"Case report: report of two cases of interstitial lung disease caused by novel compound heterozygous variants in the ABCA3 gene.","volume":"13","author":"Chen","year":"2022","journal-title":"Front Genet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s10156-005-0416-9","article-title":"The role of serum KL-6 measurement in common pediatric respiratory infections.","volume":"12","author":"Kubota","year":"2006","journal-title":"J Infect Chemother"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1098602","DOI":"10.3389\/fimmu.2023.1098602","article-title":"KL-6 levels in the connective tissue disease population: typical values and potential confounders-a retrospective, real-world study.","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.clinbiochem.2009.06.025","article-title":"Clinical laboratory reference intervals in pediatrics: the CALIPER initiative.","volume":"42","author":"Jung","year":"2009","journal-title":"Clin Biochem"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3390\/ijms26031091","article-title":"Serum KL-6 and SP-D: markers of lung function in autoimmune-related interstitial lung diseases.","volume":"26","author":"Mia\u0327dlikowska","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e43299","DOI":"10.1097\/MD.0000000000043299","article-title":"KL-6, IL-18, and S100A8\/A9 are biomarkers of connective tissue disease-associated interstitial lung disease.","volume":"104","author":"Liu","year":"2025","journal-title":"Medicine"},{"key":"B19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1080\/10408363.2017.1379945","article-title":"The Canadian laboratory initiative on pediatric reference intervals: a CALIPER white paper.","volume":"54","author":"Adeli","year":"2017","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B20","volume-title":"Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline-Third Edition.","year":"2010"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1894242\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:45:37Z","timestamp":1788417937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1894242\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":20,"alternative-id":["10.3389\/fmed.2026.1894242"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1894242","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1894242"}}